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Summary: [IlC] McN5652 is a new radioligand specific for 5-hydroxytryptamine (5-HT; serotonin) transporters. In this study we used [IlC] McN5652 to image the 5-HT transporter sites in baboon brain by positron emission tomography (PET). Dynamic PET studies were per formed in three Papio anubis baboons. The animals were injected intravenously first with IIC-labeled (+ ) McN5652([IIC]( + )McN5652), then with pharmacologi cally inactive enantiomer IIC-labeled (-)-McN5652 ([IlC]( -)McN5652); two animals received a third study with [IIC] ( + )McN5652 after pretreatment with the spe cific 5-HT uptake site inhibitor fluoxetine (5 mg/kg). Ini tial uptake into the brain was similar for both Serotonergic neuron abnormalities have been suggested in neuropsychiatric diseases such as de pression, suicide, obsessive-compulsive disorder, anxiety, aggression, Parkinson's disease, Alzhei mer's disease, eating disorders, alcoholism, mi graine, and subarachnoidal hemorrhage (Raisman et a!., 1986; Whitford, 1986 : Zohar et a!., 1987 Shee han et a!., 1988; Wurtman, 1988; Coccaro, 1989; Mann et a!., 1989; Meltzer, 1989; Daoust et a!. 1992; Tanaka et a!., 1991; Glover et a!., 1993) . Evidence has come from indirect measurements, such as de-showed a distribution characteristic for 5-HT uptake sites. In contrast, in studies with [IIC]( -)McN5652 and in ,those with [IlC]( + )McN5652 after 5-HT uptake site blockade with fluoxetine, IIC radioactivity concentra tions were significantly lower and the distribution pattern was relatively even, The differences between [IICl( +) and (-)McN5652 were calculated for the time interval 95-125 min postinjection and used to estimate specific binding. Specific binding correlated well (r = 0.95, p < 0,001) with the known density of 5-HT uptake sites in human brain. These results indicate that [IICl( + )McN5652 is suitable for PET imaging of 5-HT uptake sites in primate brain. Key Words: Fluoxe tine-[IIC]McN5652-Papio anubis-Positron emission tomography-Serotonin uptake sites. termination of 5-hydroxytryptamine (5-HT) and its metabolites in cerebrospinal fluid (Schatzberg and Rothchild, 1992) , determination of changes of 5-HT uptake sites on peripheral platelets (Arora et a!., 1991), or autoradiographic studies on postmortem brains (Mann et a!., 1990) . A noninvasive method for in vivo investigation of serotonergic neurons has not been possible until recently, when Diksic et a!. introduced a new technique for investigation of the metabolism and transport of 5-HT in the presynap tic neurons with positron emission tomography (PET) (N agahiro et a!., 1990; Diksic et a!., 199 1; Diksic, 1992) .
Extensive efforts have also been made to radio label antidepressant drugs that bind to 5-HT uptake sites on the serotonergic neuron terminals. With these radiotracers, it will be possible to visualize and quantify these sites in the living human brain by single-photon emission computed tomography (SPECT) or PET.
Several recently developed antidepressants bind selectively to the 5-HT uptake sites. A number of these antidepressant drugs have been investigated for their suitability for PET studies including N-[methyl-II C]cyanoimipramine, N-[methyl llC]sertraline, (R,S)-N- [methyl-llC] citalopram, N[llC-methyl]paroxetine and [ 1 8F-propyl]paroxe tine, N-[methyl-II C]fluoxetine, and cis-N,N e I C]dimethyl-3-(2 1 , 4 1 -dichlorophenyl) indanamine (cis-[llC]DDPI) (Hashimoto et aI., 1987; Dannals et aI., 1989; Hume et aI., 1989; Scheffel et aI., 1990; Suehiro et aI., 1991; Suehiro et aI., 1992b) . These radioligands all have the disadvantage of high non specific binding (Crouzel et aI., 1992) . Recently, a radioiodine labeled cocain analogue, [ 1 23I]RTI-55 (CIT), has been introduced for imaging monoamine uptake sites (Carroll et aI., 1991; Innis et aI., 1991; Cline et aI., 1992; Shaya et aI., 1992) ; it binds, how ever, to both 5-HT and dopamine uptake sites (Scheffel et aI., 1992) . Another radioiodinated ligand, 1 23 1 -labeled 5-iodo-6-nitroquipazine ([ 1 23 1 ]5-I-6-NQP), seems very promising as a more selective agent for imaging the 5-HT uptake sites with SPECT (Mathis et aI., 1992; Jagust et aI., 1993) .
The antidepressant McN5652 was developed by Maryanoff et al. (1984) . The ( +) enantiomer of McN5652 has a potency for binding to 5-HT uptake sites in the nanomolar range (Ki = 0.40 nM for synaptosomal 5-HT uptake). This potency is similar to that of paroxetine and sertraline, two high affinity ligands for 5-HT uptake sites. An attractive feature of McN5652 is that its enantiomer (-) McN5652 exhibits an -150 times lower affinity for the 5-HT transporter than ( + )-McN5652 (Shank et aI., 1988) .
Recently, we have labeled racemic McN5652-Z (trans-l ,2,3,5,6,1 0/3-hexahydro-6-[4-(methyl thio)phenyl]-pyrrolo-[2,1-a]-isoquinoline) and its enantiomer with a (+) optical configuration (McN5652-X) with carbon-ll and demonstrated that these tracers show promising biological behav ior in vivo as PET agents for 5-HT uptake sites (Suehiro et aI., 1992a (Suehiro et aI., , 1993a Scheffel et aI., 1993) . In rodent brain, llC-Iabeled ( + )-McN5652 ([ 1 lC]( + )McN5652) showed markedly high uptake and long retention in target tissues (hypothalamus to-cerebellar ratio, 6.2), whereas I IC-Iabeled (-) McN5652 ([ II C]( -)McN5652) showed no specific binding in target tissues (hypothalamus-to cerebellar ratio, 1.0). The in vivo binding of the ( + ) enantiomer was specific, selective for 5-HT uptake sites, and saturable. Also, the in vivo regional dis tribution agreed well with the density of 5-HT up take sites measured in vitro.
The aim of this work was to investigate the use fulness of e I C]( + )McN5652 as a radiotracer for im aging 5-HT uptake sites in nonhuman primate brain, with a view toward applying this tracer for PET investigations in humans. For this purpose the dis tribution and kinetics of both the active enantiomer [ II C]( + )McN5652 and the inactive enantiomer e I C]( -)McN5652 were studied in the baboon brain by dynamic PET imaging. In addition, blocking studies were performed after treatment with fluox etine, a specific antagonist of the 5-HT transporter. Differences between radioactivity concentrations of [llC]( +)and [llC]( -)McN were calculated and compared with the known regional densities of 5-HT uptake sites.
MATERIALS AND METHODS

Radiotracer preparation
[IIC]( + )McN5652 and [IIC]( -)McN5652 were synthe sized by a procedure described previously (Suehiro et aI., 1992a) . Briefly, the normethyl precursor and [IIC]jodomethane were reacted at 30-40°C for 1 min in N, N-dimethylformamide. Purification was performed by HPLC using a semipreparative reversed-phase C-18 col umn. The average specific activity was 2,533 ± 1,153 mCill-lmol for [IIC]( -)McN5652 and 1,735 ± 585 mCi/ I-lmol for [llC]( + )McN5652 at the time of injection.
Animal preparation
The experimental protocols were approved by the An imal Care and Use Committee of The Johns Hopkins Medical Institutions. Three baboons (Papio anubis) weighing between 22.7 and 34.5 kg were used for PET imaging studies. The animals were fasted for 12 h and then anesthetized with an intramuscular dose of 10 mg/kg Saffan (Pittman-Moore, Harefield, UK) together with 0.03 mg/kg Robinul. For maintaining anesthesia, Saffan diluted with isotonic saline (l :5) was infused intrave nously at a rate of 80-120 ml/h as needed.
Oxygen saturation of circulating blood was measured with a pulse oximeter (Nellcor Inc., Hayward, CA, U.S.A.); an oxygen saturation of >80% was maintained throughout the study. The animals were intubated with an endotracheal tube and ventilated with an average tidal volume of 400 ml, at an average frequency of 8 breaths/ min. Circulatory volume was maintained by intravenous infusion of isotonic saline. Two catheters were placed in upper-extremity veins for infusion of anesthetic drug and tracer injection. A 20-G cannula was inserted into the anterior tibial or distal femoral artery for continuous pres sure monitoring (Spacelabs Model 90603A). ECG and heart rate were also measured continuously.
A headholder and a thermoplastic mask were used for head immobilization. A computed tomography (CT) scan (Siemens Somato DR3) and laser guides were used for localization of the reference plane, for identification of individual brain regions, and for reproducible positioning of the animals. Brain structures were identified according to the published atlases of the baboon brain (Swindler and Wood, 1973; Riche et aI., 1988) .
Three animals were investigated with [IIC]( + )McN5652 and [11C]( -)McN5652. One of these baboons was used again after 56 days for imaging with [IIC]( + )McN5652 and e lC]( -)McN5652. In two animals an additional blocking study was performed with [IlCl( + )McN5652 after premedication with fluoxetine; 5 mg/kg fluoxetine was administered intravenously over 25 min; the [IlCl( + )McN5652 tracer was injected as a bolus 5 min after the end of infusion.
Tracer binding to red blood cells and proteins
To measure binding to blood cells approximately 100 fl.Ci of radioactive tracer was placed in 2 ml of whole blood and mixed thoroughly. A 50-fl.1 aliquot was re moved, the remainder was centrifuged, and 50 fl.l of plasma was pipetted. Blood cell binding (percentage) was calculated from Eq. (1):
Awhole blood
where, A = activity and Hct = hematocit.
(1)
Plasma protein binding was measured using Centri free (Amicon) micropartition system units (Sadzot et aI., 1991) .
Plasma metabolites
Four arterial blood samples were drawn (before injec tion and at 5, 15, and 30 min after tracer injection) for determination of plasma metabolites. Metabolite analysis in plasma samples was performed by methanol extraction through SEP-PAK cartridges, followed by HPLC (solid phase, Alltech Econosil C18 column; mobile phase, 50/ 50% acetonitrile/water buffered with 0.1 M ammonium formate). Radioactivity was measured continuously and analyzed using the Dynamax software package (Rainin).
PET imaging
A transmission scan with a lO-mCi gallium-68 source was obtained first and was used for attenuation correction of the PET images. Dynamic PET studies were acquired using our GE-4096+ PET scanner with the following im age sequence: three images of 5-min duration, then two of IO-min, three of 20-min, and one oDO-min duration, end ing the studies 125 min after the start. PET images were reconstructed by filtered back-projection using a Ramp filter.
Data analysis
After attenuation and decay correction, the images were displayed and correlated with CT scans. Regions of interest were defined for the following brain structures: frontal, temporal, parietal, and occipital cortex, head of the caudate nucleus, thalamus, hypothalamus, mid brain, and cerebellum (Fig. 1) These regions of interest were used for calculation of radio activity within the baboon brain.
RESULTS
[ 1l C]McN5652 binding to blood components and metabolism
The apparent protein binding of both was probably less since a very high proportion of radioactivity was retained on the components of the Centrifree unit (66 ± 7% for [IIC]( + )McN5652 and 60 ± 17% for [IIC]( -)McN5652). Because of a dy namic equilibrium among the plasma, the separa tion unit, and the ultrafiltrate, the exact amount of protein binding cannot be calculated, but it is ex pected to be >80%. Binding to blood cells was 75 ± 2 and 71 ± 13% for [IIC]( + )McN5652 and [" C]( -)McN5652, respectively. The difference be tween the two enantiomers was not significant. Analysis of plasma for metabolites revealed that the authentic radioligand eluted at �6-7 min from the HPLC column. The metabolites appeared to be more polar, with an elution time between 1 and 4 min. Metabolism of both enantiomers was relatively rapid. At 5 min postinjection 30--40% of the radio activity was metabolized, and this proportion in creased to 70% at 15 min and to 80-90% at 30 min postinjection. Differences between the two enantio mers were not significant.
Distribution in the brain
Distribution of [' IC]( + )McN5652 was deter mined with PET at 95-125 min postinjection. It was characteristic for the distribution of 5-HT uptake sites. Prominent uptake occurred in the midbrain, hypothalamus, thalamus, striatum, and pons. Inter mediate activity was found in the cerebral cortex, with minimal activity in the cerebellum and white matter (Fig. 2) . The (' -) enantiomer, [II C] -( -)McN5652 : did not show the typical distribution of the ( +) enantiomer, but was relatively evenly distributed in all brain regions (Fig. 3) .
Tissue Fig. 4 . The ( + ) enantiomer showed longer reten tion without than with fluoxetine pretreatment and also longer retention than the (-) enantiomer. In the cerebellum there was a much smaller difference in the rate of tracer disappearance between the two enantiomers, indicating that there was much less specific binding of [' IC]( + )McN5652 in this region of the brain (Fig. 5) . A higher tracer influx was ob served after f1uoxetine; this is most probably caused by blockade of peripheral binding and thus increased availability of the tracer in the brain.
The specific binding component of radioactivity McN5652 was blocked by paroxetine (Suehiro et aI. , 1993b) . In our PET studies in nonhuman pri mates fluoxetine caused blockade of the binding of [II C]( + )McN5652, demonstrating that this binding was specific. Although blocking experiments for [I lC]( -)McN5652 were not performed in this study, it was obvious from the images obtained with the two enantiomers that the distribution of the ( + ) enantiomer followed the distribution of 5-HT trans porters but that of the (-) enantiomer did not. In the baboon brain the pattern of distribution of [II C]( + )McN5652 was characteristic for the density of 5-HT uptake sites, with high activity in the mid brain, pons, and hypothalamic regions. From autoradiographic studies performed on postmortem human brain specimens, it is known that nuclei of the midbrain, pons, and hypothalamus have very high densities of 5-HT transporters (Cor tes et aI., 1988) . With PET it is impossible to iden tify and quantify the radioactivity in small nuclei. However, average values of transporter densities of a specific structure such as the hypothalamus or midbrain can be obtained.
Kinetic modeling has not yet been achieved with this new tracer. For modeling purposes, the kinetics of the tracer in blood and brain, as well as the me tabolites, have to be known. The degree of metab olism, as reflected in the accumulation of metabo lites in peripheral plasma, was rapid for both [ II C]( +) and (-)McN5652, The disadvantage of rapid metabolism is that the unmetabolized tracer has a short residence time in the circulation, which makes the input function very short. Consequently, collection of arterial blood for assessment of the input function has to be very fast and the amount of unmetabolized drug has to be monitored constantly. Both metabolism and blood sampling influence pa rameters of tracer kinetics; particularly, the param eter that describes the uptake of the tracer into brain tissue from blood is influenced by the accu racy of the input function. To minimize error, slow injection of the tracer may be necessary; this may be hampered by the high degree of adhesion of McN5652 to plastic syringes that we observed dur ing our experiments .
The brevity of the input function, together with a rapid accumulation in the brain and an almost irreversible tracer binding in regions known to be rich in 5-HT uptake sites, indicates high tracer ex traction and stable binding to the 5-HT transporter. Having a tracer with a very short input function and two enantiomers, one with and one without specific binding, may make the assessment of specific bind ing feasible. The faster the release of the active ( + ) enantiomer [IIC]( + )McN5652, i.e., the closer to the kinetics of the inactive enantiomer e lC]_ ( -)McN5652, the lower the density of uptake sites. The difference between the uptake of the active and that of the inactive enantiomers, an estimate of spe cific binding, reflected the regional density of up take sites, as was indeed demonstrated by the high correlation coefficient of 0.95 (p < 0.001; Fig. 6 ).
Specific binding was highest in the midbrain and hypothalamus and lowest in the cerebellum, con cordant with the respective densities of 5-HT trans porters in these regions.
In the baboon studies presented here, two meth ods were used to determine regional specific bind ing of the [IIC]( + )McN5652 tracer: (a) the "sub traction" method, in which specific binding was calculated from differences between the radioactiv ity concentration obtained with [ 11 C]( + )-and that with [IIC]( -)McN5652 and (b) the "blocking" method, in which specific binding was estimated from the decrease in [ 11 C]( + )McN5652 radioactiv ity after intravenous administration of a high dose (5 mg/kg) of the specific 5-HT uptake site inhibitor fluoxetine. Fluoxetine pretreatment led to signifi cantly enhanced initial uptake, probably due to the blockade of peripheral binding sites and increased availability of the tracer (Figs. 4 and 5) . Comparison of estimates of specific binding obtained by the two methods resulted in a high correlation (r = 0.81, p < 0.002), although values of specific binding ob tained by treatment with fluoxetine appeared to be greater in most of the regions than those obtained by the Laruelle and Maloteaux (1989) , method. Specific binding in the hypothalamus, e.g., was estimated to be 61 % with fluoxetine block but 42% with the subtraction method. Interestingly, these data stand in contrast to previous studies in mice obtained 60 min after tracer injection (Suehiro et a!., 1993b) , in which an overestimation of specific binding was noted when the subtraction method was applied. These differences may be the result of differences in tracer kinetics in the different species or may result from the limited accuracy of PET data obtained 95 to 125 min after injection, when radio activity counts are extremely low. Nevertheless, it is recognized that accurate correction for nonspe cifically bound tracer is an important issue and war rants further investigation. The kinetics of the [ 1 lC]( + )McN5652 tracer in the baboon were found to be considerably slower than those in rodents. Time-activity curves showed increasing radioactivity , accumulation in the mid brain and an, increasing midbrain-to-cerebellar ra tio, to 1.5 on average, at 95-125 min postinjection. This value, which is often used to express specific binding, was close to the brain stem-to-cerebellar ratio of 1.62 obtained with SPECT and [ 1 23 1 ]5-1 -6-NQP 5 h post tracer injection in adult Macaca (Ja gust et a!., 1993). Because of the longer half-life of iodine-123, SPECT measurements could be per formed as late as 8.5 h after tracer injection and revealed a further increase in the brain stem-to cerebellar ratio to 2.31 (Jagust et a!., 1993) . The brain stem-to-cerebellar (or midbrain-to-cerebellar) ratio with both PET and SPECT is expected to be higher in the human brain because of the larger size and more favorable count recovery. Also, the spe cific binding of e lC]( + )McN5652 rises beyond 2 h, i.e., beyond the time at which accurate measure ments of carbon-II radioactivity are feasible. Therefore, a ligand labeled with a longer half-life radioisotope, e.g., fluorine-18, but with an equally high affinity toward the 5-HT transporter, could be preferable. However, despite the slow kinetics of [IIC]( + )McN5652 and the relatively high nonspe cific binding of the tracer, we are encouraged by the results of the baboon studies presented here and intend to apply the tracer to image 5-HT transporter sites in humans.
CONCLUSIONS
[ 11 C]( + )McN5652 shows a distribution charac teristic for 5-HT uptake sites: high activity in the midbrain, pons, and hypothalamic regions, interme diate radioactivity in the thalamus and basal gan glia, and the lowest activity in the cerebellum. This distribution correlates well with the known density of 5-HT uptake sites in human brain. Thus, [II C] ( + )McN5652 is suitable for PET imaging of 5-HT uptake sites in primate brain.
